Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

ABSTRACT:

Aims

Smartphone-based digital screening was shown to increase the detection rate of atrial fibrillation (AF) requiring oral anticoagulation (OAC) compared with usual care. In this pre-specified subgroup analysis of the eBRAVE-AF trial, we explored sex-specific differences in digital AF-screening.

Methods and results

In eBRAVE-AF (NCT04250220), participating policyholders of a German health insurance company were randomly assigned to a 6-month digital or conventional AF-screening strategy. For digital screening, participants used smartphone-based photoplethysmography (PPG) to detect pulse wave irregularities, which were confirmed using 14-day external ECG-recorders. The primary endpoint was newly diagnosed AF treated with OAC. After 6 months, participants were assigned to a s

SUBMITTER: Freyer L 

PROVIDER: S-EPMC12450515 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature